SCHEMBL9465007

SCHEMBL9465007

O=C(Oc1ccccc1)c1ccc2nn[nH]c2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.57
ALDH1A1 P00352 4/20 0.57
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
NSD2 O96028 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.43
PARP10 Q53GL7 1/20 0.42
HTT P42858 1/20 0.42
ALOX5 P09917 1/20 0.41
PRSS1 P07477 1/20 0.41
ACR P10323 1/20 0.41
TMPRSS15 P98073 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
MAPK1 P28482 1/20 0.40
CHEK2 O96017 1/20 0.40
KDM4E B2RXH2 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1080719 0.89 MAPT (0.57) MAPTALDH1A1MEN1KMT2ANSD2
SCHEMBL14606478 0.86 KMT2A (0.53) MAPTALDH1A1MEN1KMT2APARP10
SCHEMBL9871375 0.79 KDM4E (0.52) MAPTALDH1A1HTTTDP1KDM4E
SCHEMBL29510973 0.78 TDP1 (0.51) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL264413 0.78 TDP1 (0.51) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL13411810 0.77 ALDH1A1 (0.51) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
Benzotriazole SCHEMBL9019464 0.76 NR4A2 (0.39) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL452867 0.75 PKN1 (0.53) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL6152812 0.75 ALDH1A1 (0.55) MAPTALDH1A1MEN1KMT2ANSD2
SCHEMBL20260490 0.75 PDGFRB (0.43) MAPTMEN1KMT2AHTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325108-A1 COLOR PHOTOGRAPHIC MATERIALS WITH MAGENTA MINIMUM DENSITY DYES LASER PACIFIC MEDIA CORPORATION 2009-12-31 US disclosed
US-7632632-B1 Color photographic materials with magenta minimum density dyes EASTMAN KODAK COMPANY (US) 2009-12-15 US disclosed
US-7629112-B1 Color photographic materials with yellow minimum density colorants EASTMAN KODAK COMPANY (US) 2009-12-08 US disclosed
US-20090297992-A1 COLOR PHOTOGRAPHIC MATERIALS WITH YELLOW MINIMUM DENSITY COLORANTS KODAK (NEAR EAST) INC. 2009-12-03 US disclosed
US-20090234131-A1 INFRARED DYE FOR SILVER HALIDE-BASED PHOTOGRAPHIC ELEMENTS EASTMAN KODAK COMPANY (US) 2009-09-17 US disclosed
US-20090233247-A1 INFRARED DYE FOR SILVER HALIDE-BASED PHOTOGRAPHIC ELEMENTS EASTMAN KODAK COMPANY 2009-09-17 US disclosed
US-7241562-B2 Color photographic element having improved speed EASTMAN KODAK COMPANY (US) 2007-07-10 US disclosed
US-7175975-B2 Photographic material with improved development inhibitor releases EASTMAN KODAK COMPANY (US) 2007-02-13 US disclosed
US-5270156-A Silver halide color photographic light sensitive material KONICA CORPORATION (JP) 1993-12-14 US disclosed
EP-0536889-A1 Silver halide color photographic light sensitive material KONICA CORPORATION (JP) 1993-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090234131-A1 INFRARED DYE FOR SILVER HALIDE-BASED PHOTOGRAPHIC ELEMENTS IK, HTT, HYPK MAPT 225/4885ALDH1A1 322/4885MEN1 4619/4885
US-20090233247-A1 INFRARED DYE FOR SILVER HALIDE-BASED PHOTOGRAPHIC ELEMENTS IK, HYPK, HTT MAPT 285/4885ALDH1A1 451/4885MEN1 4521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.